EUVIMEDEUVIMED entdecken
Crossref

Saikosaponin D Improves Diarrhea-Predominant Irritable Bowel Syndrome by Regulating the Brain–Gut Axis: Based on Changes in the Gut HMGB1–TLR4/NF-κB Pathway and Hypothalamic HPA Axis

Guilin Dong, Ao Li, Haizhou Zeng, Xinran Li, Yanli Xiong, Xiaoqing Xu, Jingjing Li, Yunxia Kuang, Chunli Lu, Guoqiang Qian

Digestive Diseases and Sciences · 2026

DOI: 10.1007/s10620-026-10165-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2026. Verfasst von Guilin Dong und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Hauptthemen laut MEDLINE: Saponins, Oleanolic Acid, Irritable Bowel Syndrome, HMGB1 Protein. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Study on the mechanism of Sini San improving IBS-D through Nesfatin-1-mediated HMGB1/TLR4/NF-κB signaling pathway based on the theory of liver depression and s…, Correlation study on the mechanism of iron deposition and ferroptosis initiation in brain tissue induced by inflammatory bowel disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SaponinsOleanolic AcidIrritable Bowel SyndromeHMGB1 ProteinDiarrheaBrain-Gut AxisHypothalamo-Hypophyseal SystemPituitary-Adrenal SystemAnimalsToll-Like Receptor 4MaleNF-kappa BSignal TransductionMiceDisease Models, AnimalGastrointestinal MicrobiomeIntestinal Barrier FunctionAcetic Acid

Stichwörter der Autor:innen

Brain–gut axisDepressionDiarrhea-predominant irritable bowel syndrome (IBS-D)Gut microbiotaInflammationSaikosaponin D

Substanzen

Saponinssaikosaponin DOleanolic AcidHMGB1 ProteinToll-Like Receptor 4NF-kappa BTlr4 protein, mouseHMGB1 protein, mouseAcetic Acid

Autor:innen und Institutionen

  • School of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
  • Laboratory of Oncology and Immunology, School of Basic Medical Sciences, Guangdong Provincial Experimental Teaching Demonstration Center for TCM Clinical Skills, Guangdong Pharmaceutical University, 280 Huandong Road, U…
  • Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, China.
  • Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong Pharmaceutical University, 280 Huandong Road, University Town, Guangzhou, 510006, Guangdong, China.
  • School of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China. tgqqian@gdpu.edu.cn.

Förderung

  • Study on the mechanism of Sini San improving IBS-D through Nesfatin-1-mediated HMGB1/TLR4/NF-κB signaling pathway based on the theory of liver depression and s…
  • Correlation study on the mechanism of iron deposition and ferroptosis initiation in brain tissue induced by inflammatory bowel disease

Zitieren

APA

Dong, G., Li, A., Zeng, H., Li, X., Xiong, Y., Xu, X., Li, J., Kuang, Y., Lu, C., & Qian, G. (2026). Saikosaponin D Improves Diarrhea-Predominant Irritable Bowel Syndrome by Regulating the Brain–Gut Axis: Based on Changes in the Gut HMGB1–TLR4/NF-κB Pathway and Hypothalamic HPA Axis. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-10165-8

Vancouver

Dong G, Li A, Zeng H, Li X, Xiong Y, Xu X, et al. Saikosaponin D Improves Diarrhea-Predominant Irritable Bowel Syndrome by Regulating the Brain–Gut Axis: Based on Changes in the Gut HMGB1–TLR4/NF-κB Pathway and Hypothalamic HPA Axis. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-10165-8

BibTeX
@article{Dong2026,
  author = {Dong, Guilin and Li, Ao and Zeng, Haizhou and Li, Xinran and Xiong, Yanli and Xu, Xiaoqing and Li, Jingjing and Kuang, Yunxia and Lu, Chunli and Qian, Guoqiang},
  title = {Saikosaponin D Improves Diarrhea-Predominant Irritable Bowel Syndrome by Regulating the Brain–Gut Axis: Based on Changes in the Gut HMGB1–TLR4/NF-κB Pathway and Hypothalamic HPA Axis},
  journal = {Digestive Diseases and Sciences},
  year = {2026},
  doi = {10.1007/s10620-026-10165-8}
}
Kostenlos starten →